Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-18 4:30 pm Unchanged | 13G | ANAPTYSBIO INC ANAB | Fairmount Funds Management LLC | 0 0.000% | 0 (Unchanged) | View |
| 2024-11-21 6:30 pm Purchase | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 7,941,690 19.990% | 17 (+0.00%) | View |
| 2024-11-14 4:15 pm Sale | 13G | Terns Pharmaceuticals Inc. TERN | Fairmount Funds Management LLC | 0 0.000% | -6,632,015 (Position Closed) | View |
| 2024-11-14 4:15 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | Fairmount Funds Management LLC | 3,204,841 7.900% | 3,204,841 (New Position) | View |
| 2024-11-14 4:15 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Fairmount Funds Management LLC | 5,868,045 9.900% | 2,234,080 (+61.48%) | View |
| 2024-11-14 4:15 pm Purchase | 13G | Enliven Therapeutics Inc. ELVN | Fairmount Funds Management LLC | 3,202,798 6.800% | 1,071,429 (+50.27%) | View |
| 2024-10-17 7:00 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Fairmount Funds Management LLC | 6,620,311 9.900% | 6,620,311 (New Position) | View |
| 2024-09-17 9:00 pm Purchase | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 15,556,685 17.950% | 1,600,000 (+11.46%) | View |
| 2024-09-13 4:57 pm Purchase | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 7,941,673 19.990% | 1,330,418 (+20.12%) | View |
| 2024-09-06 5:08 pm Purchase | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 6,611,255 19.990% | 6,611,255 (New Position) | View |
| 2024-06-13 06:06 am Purchase | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 11,330,141 9.900% | 1,343,585 (+13.45%) | View |
| 2024-04-25 4:40 pm Purchase | 13D | SPYRE THERAPEUTICS, INC SYRE | Fairmount Funds Management LLC | 4,508,579 11.170% | 3,672,120 (+439.01%) | View |
| 2024-04-01 6:38 pm Unchanged | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 13,956,685 18.640% | 0 (Unchanged) | View |
| 2024-04-01 6:34 pm Sale | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 2,957,385 9.990% | -3,362 (-0.11%) | View |
| 2024-04-01 6:30 pm Sale | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 9,986,556 9.900% | -31,519 (-0.31%) | View |
| 2024-04-01 5:42 pm Sale | 13D | Apogee Therapeutics Inc. APGE | Fairmount Funds Management LLC | 4,762,558 9.990% | -640,495 (-11.85%) | View |
| 2024-03-27 4:37 pm Sale | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 10,018,075 9.900% | -13,061,066 (-56.59%) | View |
| 2024-02-16 6:55 pm Purchase | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 23,079,141 18.890% | 3,116,577 (+15.61%) | View |
| 2024-02-14 3:49 pm Sale | 13G | Nuvalent Inc. NUVL | Fairmount Funds Management LLC | 1,924,626 3.400% | -864,355 (-30.99%) | View |
| 2024-02-14 3:48 pm Sale | 13G | Trevi Therapeutics Inc. TRVI | Fairmount Funds Management LLC | 0 0.000% | -6,018,465 (Position Closed) | View |